KUVATRIS THERAPEUTICS, INC. Shareholders' Equity
KUVATRIS THERAPEUTICS, INC. had Shareholders' Equity of -$1.93 million as of 2024-09-30, per its 10-Q filed 2026-01-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-01-14
- 2024-09-30: Stockholders' Equity Attributable to Parent -$1.93M.
- 2024-06-30: Stockholders' Equity Attributable to Parent -$1.81M.
- 2024-03-31: Stockholders' Equity Attributable to Parent $1.19M.
- 2023-12-31: Stockholders' Equity Attributable to Parent $3.39M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2024-09-30 | -$1.93M 10-Q · filed 2026-01-14 | |
| 2024-06-30 | -$1.81M 10-Q · filed 2026-01-14 | |
| 2024-03-31 | $1.19M 10-Q · filed 2024-09-20 | |
| 2023-12-31 | $3.39M 10-Q · filed 2026-01-14 | |
| 2023-09-30 | -$536.92K 10-Q · filed 2026-01-14 | |
| 2023-06-30 | $2.27M 10-Q · filed 2026-01-14 | |
| 2023-03-31 | $2.53M 10-Q · filed 2024-09-20 | |
| 2022-12-31 | $108.80K 10-Q · filed 2026-01-14 | |
| 2022-09-30 | $2.39M 10-Q · filed 2023-11-16 | |
| 2022-06-30 | -$7.90M 10-Q · filed 2023-11-16 | |
| 2022-03-31 | -$8.06M 10-Q · filed 2023-08-09 | |
| 2021-12-31 | -$10.11M 10-K · filed 2024-03-11 | -$10.11M 10-Q · filed 2022-09-30 |
| 2021-09-30 | -$16.57M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$13.73M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | -$7.92M 10-Q · filed 2022-09-30 | |
| 2020-12-31 | -$4.63M 10-K · filed 2023-03-30 |